Sonnet BioTherapeutics Stock Quote SONN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.615

Bid

1.56

Ask

1.67

Volume

0.00 Day's Range 0.00

1.41 52 Week Range 18.7192

Market Cap

4.857M

Previous Close

1.615

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,147,134

Shares Outstanding

3,007,431

Dividend Yield

PE Ratio

-0.65

Earnings Per Share (EPS)

-2.47

Revenue

19k

Net Profit

-7.44M

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

Sector

Pharmaceutical Preparations

Industry

Management Consulting Svcs

Website

www.sonnetbio.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was $1.62. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of $ 1.41 to $ 18.7192.

Sonnet BioTherapeutics currently has 3,007,431 shares outstanding. The market capitalization of Sonnet BioTherapeutics is $4.86 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.65.

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form 8-K - Current report

Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform Technology

European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) domain fusion proteins In addition to the U.S. and EU, Sonnet’s global IP...

Form S-1 - General form for registration of securities under the Securities Act of 1933

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.075	-4.43786982249	1.69	1.87	1.53	54458	1.65849971	CS
4	-0.145	-8.23863636364	1.76	2.05	1.44	192839	1.75383013	CS
12	-1.395	-46.3455149502	3.01	4.85	1.41	1147134	1.96647319	CS
26	-4.5578	-73.8368325557	6.1728	10.02	1.41	767221	2.77320216	CS
52	-9.585	-85.5803571429	11.2	18.7192	1.41	425777	3.74814697	CS
156	-789.329	-99.7958136101	790.944	1649.4016	1.41	1908004	550.86328735	CS
260	-15324.465	-99.9894624066	15326.08	39916.8	1.41	2280573	2543.98908774	CS

SONN - Frequently Asked Questions (FAQ)

What is the current Sonnet BioTherapeutics share price?

The current share price of Sonnet BioTherapeutics is $ 1.615

How many Sonnet BioTherapeutics shares are in issue?

Sonnet BioTherapeutics has 3,007,431 shares in issue

What is the market cap of Sonnet BioTherapeutics?

The market capitalisation of Sonnet BioTherapeutics is USD 4.86M

What is the 1 year trading range for Sonnet BioTherapeutics share price?

Sonnet BioTherapeutics has traded in the range of $ 1.41 to $ 18.7192 during the past year

What is the PE ratio of Sonnet BioTherapeutics?

The price to earnings ratio of Sonnet BioTherapeutics is -0.65

What is the cash to sales ratio of Sonnet BioTherapeutics?

The cash to sales ratio of Sonnet BioTherapeutics is 255.56

What is the reporting currency for Sonnet BioTherapeutics?

Sonnet BioTherapeutics reports financial results in USD

What is the latest annual turnover for Sonnet BioTherapeutics?

The latest annual turnover of Sonnet BioTherapeutics is USD 19k

What is the latest annual profit for Sonnet BioTherapeutics?

The latest annual profit of Sonnet BioTherapeutics is USD -7.44M

What is the registered address of Sonnet BioTherapeutics?

The registered address for Sonnet BioTherapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Sonnet BioTherapeutics website address?

The website address for Sonnet BioTherapeutics is www.sonnetbio.com

Which industry sector does Sonnet BioTherapeutics operate in?

Sonnet BioTherapeutics operates in the MANAGEMENT CONSULTING SVCS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OPOFOld Point Financial Corporation	$ 39.51 (58.99%)	4
TWINTwin Disc Inc	$ 17.88 (58.93%)	168
IBACIB Acquisition Corporation	$ 16.24 (58.90%)	58
ADSEADD TEC Energy PLC	$ 23.39 (56.66%)	12
AFRIForafric Global PLC	$ 14.99 (56.15%)	19
SBFGSB Finanical Group Inc	$ 12.22 (-46.85%)	10
THRYThryv Holdings Inc	$ 10.01 (-46.01%)	4
AURAAura Biosciences Inc	$ 5.01 (-37.38%)	1
LSBKLake Shore Bancorp Inc	$ 11.01 (-30.23%)	1
INBXInhibrx Biosciences Inc	$ 9.01 (-30.21%)	30
SXTP60 Degrees Pharmaceuticals Inc	$ 0.8835 (47.99%)	19.43M
CYNCYNGN Inc	$ 0.07875 (10.92%)	17.11M
UPCUniverse Pharmaceuticals Inc	$ 0.3095 (14.67%)	9.1M
ASSTAsset Entities Inc	$ 0.7349 (33.79%)	7.52M
SFHGSamfine Creation Holdings Group Ltd	$ 1.56 (56.00%)	7.11M